|
Aug 31
|
3 No-Brainer Stocks to Buy in September
|
|
Aug 31
|
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now
|
|
Aug 31
|
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000
|
|
Aug 30
|
Eli Lilly and Company (LLY): Jim Cramer’s Go-To Stock For Success
|
|
Aug 30
|
Trading on technicals in sectors like tech, retail, biotech
|
|
Aug 30
|
Eli Lilly Could Become the First $1 Trillion Pharma Stock. How Weight-Loss Drugs Can Get It There.
|
|
Aug 30
|
Bayer Initiates Late-Stage Study on Investigational NSCLC Drug
|
|
Aug 30
|
ESC 2024: Retatrutide improves lipid and cardiovascular risk profile in Phase II trial
|
|
Aug 30
|
Pharma Stock Roundup: LLY Offers Cheap Zepbound, EU Okays Some Drugs
|
|
Aug 30
|
The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
|
|
Aug 30
|
Analysts Say This Stock Is Likely To Hit $1 Trillion Next
|
|
Aug 30
|
Think Eli Lilly Stock Has Peaked? These 10 Words From the CEO May Change Your Mind
|
|
Aug 30
|
Wegovy reduces Covid-19 deaths and illness, study finds
|
|
Aug 30
|
Why Hims & Hers Health Stock Was Falling This Week
|
|
Aug 29
|
Lilly (LLY) Is Considered a Good Investment by Brokers: Is That True?
|
|
Aug 29
|
Is Eli Lilly Stock a No-Brainer Buy After the Company's Brilliant Zepbound Move?
|
|
Aug 29
|
The Zacks Analyst Blog Highlights Johnson & Johnson, Kenvue and Eli Lilly
|
|
Aug 29
|
Bioventus and Pool have been highlighted as Zacks Bull and Bear of the Day
|
|
Aug 9
|
Prediction: This Weight Loss Stock Will Be Acquired Within the Next Year
|
|
Aug 9
|
Eli Lilly Is Gaining on Novo Nordisk in the Obesity Race
|